
Karnataka to fully fund joint surgeries in government hospitals
Until now, the state reimbursed only three-fourths of the total surgery cost, which often left hospitals struggling to manage implant expenses and surgical logistics.
A key component of the policy is the mentor surgeon model, which pairs experienced orthopaedic surgeons from private or government institutions with PHIs that have infrastructure, but lack surgical expertise. Under this, mentor surgeons visit government hospitals to train local teams through hands-on procedures.
The new order also promises higher financial incentives to these mentor surgeons, depending on the hospital's level and the type of surgery performed.
Private mentor surgeons will receive incentives calculated on the full package cost, while government or autonomous institution surgeons acting as mentors will be paid based on 75% of the procedure cost.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


United News of India
12 hours ago
- United News of India
1.78 lakh Ayushman Arogya Mandirs operational across India: Govt
New Delhi, Aug 1 (UNI) A total of 1,78,154 Ayushman Arogya Mandirs (AAMs), formerly known as Ayushman Bharat Health and Wellness Centres (AB-HWCs), have been operationalised across the country as on July 15, 2025, the government said today "The estimated cost for establishment and maintenance of each AAM is approximately Rs 17.03 lakh, including one-time and recurring annual costs. Funding for AAMs is approved through the National Health Mission's Programme Implementation Plan, submitted by States and Union Territories," Union Minister of State for Health and Family Welfare, Prataprao Jadhav, shard these details in a written reply to the Lok Sabha. The Ministry also highlighted the 'Free Diagnostics Service Initiative' (FDSI) launched under the National Health Mission in 2015 to provide free pathological and radiological diagnostic services at all levels of public health facilities. The initiative includes 14 tests at Sub Centres and 63 tests at Primary Health Centres. The AAMs, set up by strengthening Sub Health Centres (SHCs) and Primary Health Centres (PHCs), provide comprehensive primary healthcare, encompassing preventive, promotive, rehabilitative, and curative services. These include management of communicable and non-communicable diseases, reproductive and child healthcare, and other health issues. Equipped with upgraded infrastructure, essential drugs, diagnostics, trained personnel, and IT systems, the AAMs deliver twelve packages of primary healthcare services closer to people's homes, said Prataprao Jadhav. Promotive and preventive health form an integral part of care at AAMs, with wellness activities such as yoga, cycling, and meditation being conducted regularly. As of June 30, 2025, over 5.73 crore wellness sessions have been organised. The Ayushman Bharat Digital Mission (ABDM) aims to establish a digital health ecosystem enabling interoperability of health data across public and private institutions to ensure seamless care. So far, 79.75 crore Ayushman Bharat Health Account (ABHA) IDs have been generated and 65.34 crore Electronic Health Records (EHR) have been linked, said the Minister. UNI AJ RN


Time of India
a day ago
- Time of India
Gujarat becomes leading national centre for lung cancer treatment; 4,397 patients treated in 5 years
Gandhinagar: Inspired by Prime Minister Narendra Modi's vision of "Healthy India, Prosperous India," the Gujarat government, under the leadership of Chief Minister Bhupendra Patel, is advancing healthcare services across Gujarat, said a statement from the CMO. The Gujarat Cancer and Research Institute (GCRI) in Ahmedabad has emerged as a crucial centre in this mission, providing advanced treatment to thousands of lung cancer patients over the past five years. Through focused initiatives and continuous innovation, Gujarat is paving the way for a healthier society, benefiting the nation as a whole. To position Gujarat as a global centre for medical excellence, the government of Gujarat, under the leadership of Chief Minister Bhupendra Patel, has earned the trust of patients from across India. This increasing confidence is reflected in the rising number of people seeking lung cancer treatment in Gujarat over the past five years. As per the statement, from 2020 to 2024, the Gujarat Cancer and Research Institute (GCRI) in Ahmedabad treated a total of 4,397 lung cancer patients (3,597 men, 799 women, and 1 child). The year-wise figures show a consistent increase: 700 patients in 2020, 813 in 2021, 865 in 2022, 933 in 2023, and a record 1,086 in 2024. The PMJAY-MA scheme has played a crucial role in making lung cancer treatment easily available in Gujarat. Over the past five years, thousands of patients have received advanced care through this initiative, providing significant relief to economically weaker sections. By reducing financial burdens and ensuring timely treatment, the scheme has helped save many lives. Notably, 1,426 lung cancer patients from other states have also sought treatment in Gujarat, drawn by the state's modern medical facilities. This growing trust reflects Gujarat's emergence as a reliable centre for cancer care, not only for the people of Gujarat but for patients from across India. Marking World Lung Cancer Day, the Gujarat Cancer and Research Institute (GCRI) has urged citizens to take proactive steps towards prevention, early detection, and timely treatment of lung cancer. The institute noted that more than 40 per cent of lung cancer cases in India are diagnosed at an advanced stage due to limited awareness, making treatment more complex and outcomes less favourable. GCRI has especially appealed to high-risk people, such as long-term smokers and those exposed to environmental pollutants, to undergo low-dose CT scans for early screening. Experts believe that timely diagnosis and swift medical intervention significantly improve survival and quality of life. GCRI Director Dr Shashank Pandya said, "Awareness is our greatest defence against lung cancer. Early screening, quitting tobacco, and recognising warning signs can save lives. At GCRI, we are committed to providing state-of-the-art diagnostics and holistic care for every patient." Driven by robust healthcare services and state-of-the-art infrastructure, Gujarat is becoming a preferred centre for medical tourism, not just for India but for the world. The Gujarat Cancer and Research Institute (GCRI) in Ahmedabad offers cancer treatment on par with global standards, using advanced technologies like CyberKnife, True Beam, TomoTherapy, and Robotic Surgery, along with high-end diagnostics such as NGS, PET-CT, PSMA Scan, and 3 Tesla MRI.


New Indian Express
a day ago
- New Indian Express
Karnataka to fully fund joint surgeries in government hospitals
BENGALURU: In a bid to expand access to advanced orthopaedic care in public hospitals, the state government has announced that 100% of the cost of Total Knee Replacement (TKR) and Total Hip Replacement (THR) surgeries will now be reimbursed under the AB-PMJAY-CM's Arogya Karnataka (ArK) scheme. Public health institutions (PHIs) will receive the entire package cost — Rs 65,000 for TKR and Rs 1 lakh for THR, an increase from the earlier 75% reimbursement rate. Until now, the state reimbursed only three-fourths of the total surgery cost, which often left hospitals struggling to manage implant expenses and surgical logistics. A key component of the policy is the mentor surgeon model, which pairs experienced orthopaedic surgeons from private or government institutions with PHIs that have infrastructure, but lack surgical expertise. Under this, mentor surgeons visit government hospitals to train local teams through hands-on procedures. The new order also promises higher financial incentives to these mentor surgeons, depending on the hospital's level and the type of surgery performed. Private mentor surgeons will receive incentives calculated on the full package cost, while government or autonomous institution surgeons acting as mentors will be paid based on 75% of the procedure cost.